Stay updated with breaking news from Development Command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Since its enactment in 2017, Public Law No. 115-92 has significantly boosted the availability of medical products that protect and treat military personnel. Designed to overcome the...
Non-Dilutive Funding to Accelerate Development of Artificial Intelligence Driven Handheld DeepView® ... | April 18, 2023
Astrocyte Pharmaceuticals Inc. announced initiation of a phase 1b study of AST-004, a small molecule adenosine A3/A1 receptor agonist for stroke and traumatic brain injuries that will be evaluated in healthy volunteers.According to a release from Astrocyte, the study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AST-004 as a loading dose followed by continuous
The Multi-Domain Operations Radar for Air-Launched Effects (ALE) has entered the competitive phase of the acquisition process.
San Antonio, TX (PRWEB) March 16, 2023 -- Prytime Medical Inc, The REBOA Company™, the leading innovator and global provider of lifesaving REBOA products for